Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17614) 17614
Publication (1813) 1813
Book Review (87) 87
Book Chapter (68) 68
Conference Proceeding (41) 41
Newspaper Article (29) 29
Book / eBook (22) 22
Magazine Article (10) 10
Data Set (3) 3
Dissertation (1) 1
Newsletter (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (9238) 9238
chelating agents - pharmacology (7039) 7039
humans (6867) 6867
index medicus (4704) 4704
male (4042) 4042
rats (3889) 3889
biochemistry & molecular biology (3238) 3238
calcium - metabolism (2670) 2670
chelating agents (2567) 2567
mice (2554) 2554
female (2536) 2536
iron - metabolism (2343) 2343
egtazic acid - pharmacology (2155) 2155
iron chelating agents - pharmacology (1892) 1892
chelating agents - chemistry (1708) 1708
kinetics (1661) 1661
iron (1614) 1614
egtazic acid - analogs & derivatives (1609) 1609
cells, cultured (1399) 1399
pharmacology & pharmacy (1384) 1384
chelating agents - therapeutic use (1355) 1355
time factors (1349) 1349
neurosciences (1316) 1316
oxidative stress (1314) 1314
dose-response relationship, drug (1236) 1236
in vitro techniques (1197) 1197
chelating agents - metabolism (1184) 1184
calcium (1159) 1159
cell biology (1056) 1056
hydrogen-ion concentration (1040) 1040
edetic acid - pharmacology (1036) 1036
enzyme inhibitors - pharmacology (965) 965
oxidation-reduction (953) 953
adult (939) 939
iron chelating agents - therapeutic use (935) 935
toxicology (922) 922
rats, sprague-dawley (896) 896
analysis (883) 883
liver - metabolism (862) 862
rats, wistar (852) 852
deferoxamine - pharmacology (832) 832
research (827) 827
proteins (823) 823
iron chelating agents - metabolism (813) 813
metabolism (794) 794
cell line (782) 782
copper (777) 777
cells (759) 759
physiology (735) 735
zinc (732) 732
antioxidants - pharmacology (725) 725
copper - metabolism (723) 723
toxicity (698) 698
cell line, tumor (694) 694
middle aged (684) 684
apoptosis (679) 679
expression (673) 673
research article (666) 666
article (665) 665
hematology (656) 656
in-vitro (655) 655
endocrinology & metabolism (643) 643
tissue distribution (628) 628
environmental sciences (626) 626
zinc - metabolism (623) 623
physiological aspects (605) 605
protein binding (605) 605
antioxidants (589) 589
microbiology (589) 589
reactive oxygen species - metabolism (584) 584
chelation (581) 581
biophysics (580) 580
ligands (580) 580
deferoxamine (568) 568
calcium - pharmacology (564) 564
binding sites (549) 549
inhibition (540) 540
activation (537) 537
molecular sequence data (527) 527
iron chelating agents - chemistry (521) 521
free radicals (520) 520
cattle (518) 518
structure-activity relationship (513) 513
rabbits (508) 508
oncology (501) 501
chemistry, medicinal (498) 498
enzymes (496) 496
apoptosis - drug effects (495) 495
edta (486) 486
lipid-peroxidation (483) 483
metals (474) 474
neurons - drug effects (465) 465
amino acid sequence (461) 461
molecular structure (461) 461
protein (459) 459
life sciences (453) 453
cell survival - drug effects (449) 449
binding (446) 446
phosphorylation (442) 442
chelating agents - administration & dosage (441) 441
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17181) 17181
Russian (146) 146
German (112) 112
French (77) 77
Japanese (49) 49
Chinese (40) 40
Italian (31) 31
Spanish (28) 28
Polish (19) 19
Portuguese (7) 7
Czech (5) 5
Ukrainian (5) 5
Dutch (3) 3
Danish (2) 2
Hungarian (2) 2
Slovak (2) 2
Bulgarian (1) 1
Croatian (1) 1
Greek (1) 1
Indonesian (1) 1
Korean (1) 1
Lithuanian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Natural product-based amyloid inhibitors
by Velander, Paul and Wu, Ling and Henderson, Frances and Zhang, Shijun and Bevan, David R and Xu, Bin
Biochemical Pharmacology, ISSN 0006-2952, 09/2017, Volume 139, pp. 40 - 55
Many chronic human diseases, including multiple neurodegenerative diseases, are associated with deleterious protein aggregates, also called protein amyloids.... 
Covalent mechanisms | Non-covalent mechanisms | Amyloid inhibitor | Natural products | Inhibition mechanisms | CLINICAL-TRIAL | PROTEIN AGGREGATION | ALZHEIMERS-DISEASE | SOLID DISPERSION | TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE | ALPHA-SYNUCLEIN AGGREGATION | BETA-PEPTIDE AGGREGATION | A-BETA | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | AROMATIC-INHIBITOR | Amyloidosis - prevention & control | Drugs, Investigational - pharmacology | Antioxidants - chemistry | Nootropic Agents - metabolism | Antioxidants - metabolism | Healthy Diet | Humans | Polyphenols - pharmacology | Drugs, Investigational - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Biological Products - pharmacology | Flavonoids - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Polyphenols - metabolism | Amyloidogenic Proteins - antagonists & inhibitors | Drugs, Investigational - chemistry | Protein Aggregation, Pathological - prevention & control | Amyloidosis - diet therapy | Drug Design | Flavonoids - pharmacology | Protein Aggregation, Pathological - diet therapy | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Chelating Agents - therapeutic use | Biological Products - therapeutic use | Chelating Agents - chemistry | Nootropic Agents - therapeutic use | Amyloidosis - drug therapy | Antioxidants - pharmacology | Chelating Agents - pharmacology | Nootropic Agents - chemistry | Drug Discovery | Protein Aggregation, Pathological - drug therapy | Amyloidogenic Proteins - metabolism | Antioxidants - therapeutic use | Biological Products - chemistry | Animals | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Flavonoids - metabolism | Polyphenols - chemistry | Biological Products - metabolism | Polyphenols - therapeutic use | Chelating Agents - metabolism | Dietary Supplements | Flavonoids - chemistry | Amyloidosis - metabolism | Nootropic Agents - pharmacology | Medicine, Experimental | Medical research | Nervous system diseases | Glycoproteins | Drug discovery | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes
by Lovejoy, David B and Jansson, Patric J and Brunk, Ulf T and Wong, Jacky and Ponka, Prem and Richardson, Des R and Institutionen för medicin och hälsa and Farmakologi and Linköpings universitet and Hälsouniversitetet
Cancer Research, ISSN 0008-5472, 09/2011, Volume 71, Issue 17, pp. 5871 - 5880
The metal-chelating compound Dp44mT is a di-2-pyridylketone thiosemicarbazone (DpT) which displays potent and selective antitumor activity. This compound is... 
CANCER-CELLS | APOPTOSIS | POTENT | INHIBITION | TRANSFERRIN | ONCOLOGY | IRON CHELATORS | AGENTS | DEATH | Lysosomes - drug effects | Acridine Orange - metabolism | Cell Survival - drug effects | Reactive Oxygen Species - metabolism | Oxidation-Reduction | Humans | Chelating Agents - pharmacology | Mitochondria - drug effects | Iron - metabolism | Antineoplastic Agents - metabolism | Lysosomes - metabolism | Copper - metabolism | Thiosemicarbazones - metabolism | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Thiosemicarbazones - pharmacology | Chelating Agents - metabolism | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Sonochemical synthesis, DNA binding, antimicrobial evaluation and in vitro anticancer activity of three new nano-sized Cu(II), Co(II) and Ni(II) chelates based on tri-dentate NOO imine ligands as precursors for metal oxides
by Abdel-Rahman, Laila H and Abu-Dief, Ahmed M and El-Khatib, Rafat M and Abdel-Fatah, Shimaa Mahdy
Journal of Photochemistry & Photobiology, B: Biology, ISSN 1011-1344, 09/2016, Volume 162, pp. 298 - 308
Three new nano sized Cu(II), Co(II) and Ni(II) complexes of imine ligand derived from the condensation of 2-amino-3-hydroxypyridine and... 
Nanoparticles | Antimicrobial activity | Synthesis | DNA interaction | Thermal analyses | Cytotoxic activity | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTIBACTERIAL | STRUCTURAL-CHARACTERIZATION | TOXICITY | ANTITUMOR-ACTIVITY | BIOPHYSICS | SCHIFF-BASES | AMINO-ACID COMPLEXES | AGENTS | X-RAY STRUCTURES | BIOLOGICAL SCREENINGS | DERIVATIVES | Anti-Infective Agents - metabolism | Anti-Infective Agents - pharmacology | Antineoplastic Agents - chemical synthesis | Humans | Oxides - chemistry | Antineoplastic Agents - metabolism | Copper - chemistry | MCF-7 Cells | Anti-Infective Agents - chemistry | Imines - chemistry | Antineoplastic Agents - pharmacology | Ultrasonic Waves | Chemistry Techniques, Synthetic | Nickel - chemistry | Chelating Agents - chemistry | Hydrodynamics | Chelating Agents - pharmacology | DNA - metabolism | Antineoplastic Agents - chemistry | Anti-Infective Agents - chemical synthesis | Organometallic Compounds - metabolism | Organometallic Compounds - chemical synthesis | Nanostructures - chemistry | Ligands | Organometallic Compounds - chemistry | Kinetics | Chelating Agents - chemical synthesis | Chelating Agents - metabolism | Cobalt - chemistry | Organometallic Compounds - pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
by Cavalli, Andrea and Bolognesi, Maria Laura and Minarini, Anna and Rosini, Michela and Tumiatti, Vincenzo and Recanatini, Maurizio and Melchiorre, Carlo
Journal of Medicinal Chemistry, ISSN 0022-2623, 2/2008, Volume 51, Issue 3, pp. 347 - 372
OXIDATIVE STRESS | CHEMISTRY, MEDICINAL | H-3 RECEPTOR ANTAGONISTS | ANTI-PARKINSON DRUG | ALZHEIMERS-DISEASE | NAD(P)H-QUINONE OXIDOREDUCTASE ACTIVITY | AMYOTROPHIC-LATERAL-SCLEROSIS | AMYLOID PRECURSOR PROTEIN | MONOAMINE-OXIDASE INHIBITION | MOLECULAR-WEIGHT COMPLEXES | CU,ZN SUPEROXIDE-DISMUTASE | Antioxidants - chemistry | Humans | Calcium Channel Blockers - therapeutic use | Cholinesterase Inhibitors - chemistry | Parkinson Disease - drug therapy | Neurodegenerative Diseases - drug therapy | Alzheimer Disease - pathology | Neurofibrillary Tangles - metabolism | Amyloid beta-Peptides - metabolism | Parkinson Disease - metabolism | Huntington Disease - drug therapy | Binding Sites | Chelating Agents - therapeutic use | Multiple Sclerosis - metabolism | Neurofibrillary Tangles - pathology | Neurodegenerative Diseases - pathology | Plaque, Amyloid - pathology | Chelating Agents - chemistry | Neurotransmitter Agents - metabolism | Alzheimer Disease - drug therapy | Antioxidants - pharmacology | Chelating Agents - pharmacology | Neurodegenerative Diseases - metabolism | Calcium Channel Blockers - pharmacology | Huntington Disease - metabolism | Antioxidants - therapeutic use | Cholinesterase Inhibitors - pharmacology | Alzheimer Disease - metabolism | Calcium Channel Blockers - chemistry | Ligands | Plaque, Amyloid - metabolism | Cholinesterase Inhibitors - therapeutic use | Acetylcholinesterase - metabolism | Multiple Sclerosis - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against Pseudomonas aeruginosa
by Ito, Akinobu and Nishikawa, Toru and Matsumoto, Shuhei and Yoshizawa, Hidenori and Sato, Takafumi and Nakamura, Rio and Tsuji, Masakatsu and Yamano, Yoshinori
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2016, Volume 60, Issue 12, pp. 7396 - 7401
Cefiderocol (S-649266) is a novel parenteral siderophore cephalosporin conjugated with a catechol moiety at the third-position side chain. The in vitro... 
EFFICACY | S-649266 | CONJUGATED MONOCARBAM | RESISTANCE | CARBAPENEMASES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | METALLO-BETA-LACTAMASES | MECHANISMS | PROTEINS | EMERGENCE | VITRO ANTIMICROBIAL ACTIVITY | Ceftazidime - pharmacology | Fluoresceins - metabolism | Pseudomonas aeruginosa - growth & development | Cephalosporins - chemistry | Fluorescent Dyes - metabolism | Anti-Bacterial Agents - metabolism | Structure-Activity Relationship | Pseudomonas aeruginosa - drug effects | Iron Chelating Agents - metabolism | Iron - metabolism | Iron Chelating Agents - chemistry | Microbial Sensitivity Tests | Biological Transport | Iron Chelating Agents - pharmacology | Pseudomonas aeruginosa - metabolism | Anti-Bacterial Agents - chemistry | Thiazoles - chemistry | Anti-Bacterial Agents - pharmacology | Iron - toxicity | Cephalosporins - pharmacology | Carbon Radioisotopes | Cephalosporins - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation
by Wu, Ming-Yu and Esteban, Gerard and Brogi, Simone and Shionoya, Masahi and Wang, Li and Campiani, Giuseppe and Unzeta, Mercedes and Inokuchi, Tsutomu and Butini, Stefania and Marco-Contelles, Jose
European Journal of Medicinal Chemistry, ISSN 0223-5234, 10/2016, Volume 121, pp. 864 - 879
Currently available drugs against Alzheimer's disease (AD) are only able to ameliorate the disease symptoms resulting in a moderate improvement in memory and... 
Human acetylcholinesterase | MAO-A | Molecular modeling | Human butyrylcholinesterase | Metal chelating properties | ADME+T properties | Antioxidant properties | MAO-B | Alzheimer's disease | Molecular docking | CHEMISTRY, MEDICINAL | ALZHEIMERS-DISEASE | CHOLINESTERASE-INHIBITORS | SEROTONIN 5-HT1A | DRUGS | POTENTIAL TREATMENT | NITRIC-OXIDE | FORCE-FIELD | OXIDASE-INHIBITORS | ADME plus T properties | RATIONAL DESIGN | HYBRIDS | Antioxidants - chemistry | Antioxidants - metabolism | Humans | Structure-Activity Relationship | Monoamine Oxidase Inhibitors - chemical synthesis | Monoamine Oxidase - chemistry | Piperidines - pharmacology | Drug Design | Indans - chemistry | Monoamine Oxidase Inhibitors - pharmacology | Piperidines - chemistry | Chemistry Techniques, Synthetic | Piperidines - metabolism | Chelating Agents - chemistry | Indans - metabolism | Acetylcholinesterase - chemistry | Antioxidants - chemical synthesis | Antioxidants - pharmacology | Chelating Agents - pharmacology | Piperidines - chemical synthesis | Monoamine Oxidase Inhibitors - metabolism | Indans - chemical synthesis | Protein Conformation | Molecular Docking Simulation | Monoamine Oxidase Inhibitors - chemistry | Chelating Agents - chemical synthesis | Chelating Agents - metabolism | Acetylcholinesterase - metabolism | Indans - pharmacology | Monoamine Oxidase - metabolism | Antioxidants | Enzymes | Monoamine oxidase | Analysis | Models | Drug discovery | Target marketing
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Microbial siderophores and their potential applications: a review
by Saha, Maumita and Saha, Maumita and Sarkar, Subhasis and Sarkar, Subhasis and Sarkar, Biplab and Sarkar, Biplab and Sharma, Bipin Kumar and Sharma, Bipin Kumar and Bhattacharjee, Surajit and Bhattacharjee, Surajit and Tribedi, Prosun and Tribedi, Prosun
Environmental Science and Pollution Research, ISSN 0944-1344, 3/2016, Volume 23, Issue 5, pp. 3984 - 3999
Siderophores are small organic molecules produced by microorganisms under iron-limiting conditions which enhance the uptake of iron to the microorganisms. In... 
Environmental Health | Ecotoxicology | Microbial ecology | Iron | Environment, general | Medicine | Siderophore | Biosensor | Environment | Waste Water Technology / Water Pollution Control / Water Management / Aquatic Pollution | Bioremediation | Environmental Chemistry | Atmospheric Protection/Air Quality Control/Air Pollution | IRON ACQUISITION | HETEROTROPHIC BACTERIA | MICROORGANISMS | ENVIRONMENTAL SCIENCES | TRANSPORT | PSEUDOMONAS-AERUGINOSA | CANCER-RISK | SOIL | ANTINEUROBLASTOMA ACTIVITY | PLANT-GROWTH | MARINE | Bacteria - metabolism | Drug Carriers - metabolism | Antimalarials - metabolism | Siderophores - metabolism | Humans | Crops, Agricultural - growth & development | Ecology | Iron Chelating Agents - metabolism | Iron - metabolism | Drug Carriers - pharmacology | Siderophores - pharmacology | Antimalarials - pharmacology | Antineoplastic Agents - metabolism | Bacteria - growth & development | Biological Transport | Iron Chelating Agents - pharmacology | Biosensing Techniques | Antineoplastic Agents - pharmacology | Crops, Agricultural - metabolism | Sickle cell anemia | Iron compounds | Biological control | Detectors | Physiological aspects | Pests | Spyware | Studies | Environmental science | Biosensors | Heavy metals
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Phenylpropanoids as naturally occurring antioxidants: From plant defense to human health
by Korkina, L.G
Cellular and Molecular Biology, ISSN 0145-5680, 2007, Volume 53, Issue 1, pp. 15 - 25
Phenylpropanoids (PPs) belong to the largest group of secondary metabolites produced by plants, mainly, in response to biotic or abiotic stresses such as... 
Antioxidants | Phytoestrogens | UV-screen | Phenylpropanoids | Anti-cancer | Metabolism | Plant defense | Anti-inflammatory | Cytoprotective action | and cytoprotective action | antioxidants | NITRIC-OXIDE SYNTHASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | PHENYLETHANOID GLYCOSIDES | ACID PHENETHYL ESTER | phytoestrogens | anti-cancer | S-PHASE ARREST | ESTROGEN-RECEPTOR | CELL BIOLOGY | BREAST-CANCER CELLS | IN-VITRO | plant defense | CAFFEIC ACID | anti-inflammatory | metabolism | P-METHOXYCINNAMIC ACID | NF-KAPPA-B | phenylpropanoids | Plant Extracts - chemistry | Reactive Oxygen Species - metabolism | Antioxidants - chemistry | Oxidative Stress | Free Radical Scavengers - chemistry | Antioxidants - metabolism | Humans | Antineoplastic Agents - therapeutic use | Anti-Inflammatory Agents - metabolism | Antineoplastic Agents - metabolism | Plant Extracts - metabolism | Free Radical Scavengers - therapeutic use | Plants - chemistry | Estrogens - metabolism | Biological Products - therapeutic use | Cytoprotection | Free Radical Scavengers - metabolism | Phenols - metabolism | Antineoplastic Agents - chemistry | Antioxidants - therapeutic use | Biological Products - chemistry | Plants - metabolism | Animals | Anti-Inflammatory Agents - chemistry | Phenols - therapeutic use | Biological Products - metabolism | Cell Line, Tumor | Phenols - chemistry | Estrogen Receptor Modulators - metabolism | Chelating Agents - metabolism | Plant Extracts - therapeutic use
Journal Article
Details down arrow
9. Full Text Metal Chelation and Inhibition of Bacterial Growth in Tissue Abscesses
by Brian D. Corbin and Erin H. Seeley and Andrea Raab and Joerg Feldmann and Michael R. Miller and Victor J. Torres and Kelsi L. Anderson and Brian M. Dattilo and Paul M. Dunman and Russell Gerads and Richard M. Caprioli and Wolfgang Nacken and Walter J. Chazin and Eric P. Skaar
Science, ISSN 0036-8075, 2/2008, Volume 319, Issue 5865, pp. 962 - 965
Bacterial infection often results in the formation of tissue abscesses, which represent the primary site of interaction between invading bacteria and the... 
Microbial growth | Kidneys | Antimicrobials | Liver | Abscesses | Neutrophils | Chelation | Reports | Mice | Infections | Staphylococcus | CALPROTECTIN | STAPHYLOCOCCUS-AUREUS | EXPRESSION | MULTIDISCIPLINARY SCIENCES | EF-HAND PROTEINS | ANTIMICROBIAL ACTIVITY | Abscess - microbiology | Abscess - metabolism | Calcium - metabolism | Zinc - metabolism | Leukocyte L1 Antigen Complex - metabolism | Gene Expression Profiling | Liver Abscess - metabolism | Liver Abscess - microbiology | Mass Spectrometry | Leukocyte L1 Antigen Complex - pharmacology | Staphylococcal Infections - microbiology | Dimerization | Neutrophils - metabolism | Kidney Diseases - metabolism | Staphylococcal Infections - metabolism | Staphylococcus aureus - genetics | Kidney Diseases - microbiology | Liver Abscess - pathology | Staphylococcal Infections - immunology | Chelating Agents - pharmacology | Kidney Diseases - immunology | Animals | Manganese - metabolism | Leukocyte L1 Antigen Complex - genetics | Abscess - immunology | Chelating Agents - metabolism | Staphylococcus aureus - drug effects | Staphylococcus aureus - growth & development | Bacterial growth | Control | Care and treatment | Immune response | Bacterial infections | Abscess | Research | Chelation therapy | Methods | Bacteria | Staphylococcus infections | Biomedical research | Immunology | Metals | Rodents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Metal Ions and Intrinsically Disordered Proteins and Peptides: From Cu/Zn Amyloid‑β to General Principles
by Faller, Peter and Hureau, Christelle and La Penna, Giovanni
Accounts of Chemical Research, ISSN 0001-4842, 08/2014, Volume 47, Issue 8, pp. 2252 - 2259
Conspectus The interaction of d-block metal ions (Cu, Zn, Fe, etc.) with intrinsically disordered proteins (IDPs) has gained interest, partly due to their... 
AFFINITY | ALZHEIMERS-DISEASE | ZN-7-METALLOTHIONEIN-3 | COPPER COORDINATION | ALPHA-SYNUCLEIN | CONFORMATION | SUPEROXIDE-DISMUTASE | ZINC-BINDING | CHEMISTRY, MULTIDISCIPLINARY | AGGREGATION | Zinc - metabolism | Humans | Chelating Agents - chemistry | Zinc - chemistry | Alzheimer Disease - pathology | Copper - chemistry | Amyloid beta-Peptides - genetics | Intrinsically Disordered Proteins - chemistry | Alzheimer Disease - metabolism | Amyloid beta-Peptides - metabolism | Copper - metabolism | Amyloid beta-Peptides - chemistry | Kinetics | Chelating Agents - metabolism | Binding Sites | Amino Acid Substitution | Hydrogen-Ion Concentration | Intrinsically Disordered Proteins - metabolism | Proteins | Analysis | Chemical properties | Research | Copper | Structure | Zinc
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Calcium depletion-mediated protease inhibition and apical-junctional-complex disassembly via an EGTA-conjugated carrier for oral insulin delivery
by Chuang, Er-Yuan and Lin, Kun-Ju and Su, Fang-Yi and Chen, Hsin-Lung and Maiti, Barnali and Ho, Yi-Cheng and Yen, Tzu-Chen and Panda, Nilendu and Sung, Hsing-Wen
Journal of Controlled Release, ISSN 0168-3659, 08/2013, Volume 169, Issue 3, pp. 296 - 305
Calcium (Ca ) has a crucial role in maintaining the intestinal protease activity and in forming the apical junctional complex (AJC) that preserves epithelial... 
Chelating agent | Enzyme inhibition | Calcium depletion | Apical junctional complex | Oral protein delivery | CHELATORS | CHITOSAN | ALPHA | POLYMER HYDROGELS | DIABETIC-RATS | CHEMISTRY, MULTIDISCIPLINARY | NANOPARTICLES | SYSTEMS | PHARMACOLOGY & PHARMACY | ABSORPTION | DERIVATIVES | BINDING | Diabetes Mellitus, Experimental - drug therapy | Nanoparticles - chemistry | Rats, Wistar | Calcium - metabolism | Hypoglycemic Agents - metabolism | Humans | Drug Carriers - chemistry | Polyglutamic Acid - analogs & derivatives | Egtazic Acid - chemistry | Hypoglycemic Agents - administration & dosage | Nanoparticles - metabolism | Diabetes Mellitus, Experimental - metabolism | Chitosan - metabolism | Peptide Hydrolases - metabolism | Caco-2 Cells | Hypoglycemic Agents - therapeutic use | Drug Carriers - metabolism | Hypoglycemic Agents - pharmacokinetics | Polyglutamic Acid - metabolism | Egtazic Acid - metabolism | Administration, Oral | Chelating Agents - chemistry | Models, Molecular | Rats | Insulin - administration & dosage | Polyglutamic Acid - chemistry | Insulin - metabolism | Animals | Chitosan - chemistry | Chelating Agents - metabolism | Insulin - pharmacokinetics | Insulin - therapeutic use | Ethylene glycol | Permeability | Proteases | Insulin | Diabetes therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Bisphosphonates: Molecular mechanisms of action and effects on bone cells, monocytes and macrophages
by Roelofs, A.J and Thompson, K and Ebetino, F.H and Rogers, M.J and Coxon, F.P
Current Pharmaceutical Design, ISSN 1381-6128, 2010, Volume 16, Issue 27, pp. 2950 - 2960
Bisphosphonates are widely used in the treatment of diseases involving excessive bone resorption, such as osteoporosis, cancer-associated bone disease, and... 
Bisphosphonate | Fpp synthase | Monocyte | Bone affinity | Protein prenylation | Osteoclast | Osteocyte | Macrophage | GROWTH-INHIBITION | protein prenylation | NITROGEN-CONTAINING BISPHOSPHONATES | macrophage | DELTA T-CELLS | osteocyte | GTP-BINDING PROTEINS | FUNCTION IN-VITRO | OSTEOCLAST PRECURSORS | ZOLEDRONIC ACID | ACUTE-PHASE RESPONSE | bone affinity | monocyte | TUMOR-ASSOCIATED MACROPHAGES | PHARMACOLOGY & PHARMACY | FPP synthase | osteoclast | POSTMENOPAUSAL WOMEN | Calcium - metabolism | Humans | Monocytes - metabolism | Bone and Bones - drug effects | Tissue Distribution | Chelating Agents - pharmacokinetics | Bone and Bones - metabolism | Drug Design | Diphosphonates - therapeutic use | Bone Density Conservation Agents - metabolism | Chelating Agents - therapeutic use | Bone Density Conservation Agents - pharmacokinetics | Bone Resorption - drug therapy | Bone Density Conservation Agents - therapeutic use | Diphosphonates - pharmacokinetics | Diphosphonates - metabolism | Chelating Agents - pharmacology | Organ Specificity | Bone Density Conservation Agents - pharmacology | Monocytes - drug effects | Macrophages - metabolism | Animals | Macrophages - drug effects | Chelating Agents - metabolism | Diphosphonates - pharmacology | Drugs | Enzymes | Animal models | Cytotoxicity | Osteocytes | Bone diseases | Minerals | Macrophages | Bisphosphonates | Survival | Clodronic acid | Bone resorption | Paget's disease | Monocytes | Osteoclasts | Skeleton | ATP | Apoptosis | Guanosinetriphosphatase
Journal Article
Details down arrow
13. Full Text Immunomodulatory and antioxidant potential of Lactobacillus exopolysaccharides
by Liu, Chin‐Feng and Tseng, Kuo‐Chuan and Chiang, Shen‐Shih and Lee, Bao‐Hong and Hsu, Wei‐Hsuan and Pan, Tzu‐Ming
Journal of the Science of Food and Agriculture, ISSN 0022-5142, 09/2011, Volume 91, Issue 12, pp. 2284 - 2291
BACKGROUND: Immunomodulation by probiotic microorganisms has become a topic of increasing interest in food microbiology. Polysaccharides are broadly used in... 
exopolysaccharide | immunomodulation | Raw 264.7 | Lactobacillus | Exopolysaccharide | Immunomodulation | IMMUNE-RESPONSE | PROBIOTIC BACTERIA | FERMENTED MILK | FOOD SCIENCE & TECHNOLOGY | PARACASEI NTU 101 | MOUSE LYMPHOCYTE-PROLIFERATION | STREPTOCOCCUS-THERMOPHILUS | IN-VITRO | CYTOKINE PRODUCTION | CELL-WALL | LACTIC-ACID BACTERIA | AGRICULTURE, MULTIDISCIPLINARY | CHEMISTRY, APPLIED | Free Radical Scavengers - pharmacology | Adjuvants, Immunologic - pharmacology | Antioxidants - chemistry | Species Specificity | Free Radical Scavengers - chemistry | Antioxidants - metabolism | Lactobacillus plantarum - metabolism | Chromatography, High Pressure Liquid | Iron Chelating Agents - metabolism | Iron Chelating Agents - chemistry | Adjuvants, Immunologic - chemistry | Surface Properties | Adjuvants, Immunologic - metabolism | Lipid Peroxidation - drug effects | Oxidation-Reduction - drug effects | Polysaccharides, Bacterial - isolation & purification | Adjuvants, Immunologic - isolation & purification | Macrophages - immunology | Probiotics - metabolism | Polysaccharides, Bacterial - chemistry | Polysaccharides, Bacterial - pharmacology | Lactobacillus - immunology | Phagocytosis - drug effects | Cytokines - metabolism | Free Radical Scavengers - metabolism |